Choroidal Neovascularization in Pathologic Myopia: Recent Developments in Diagnosis and Treatment
Author:
Publisher
Elsevier BV
Subject
Ophthalmology
Reference86 articles.
1. ___: Verteporfin therapy for subfoveal choroidal neovascularization in pathologic myopia: 3-year results of an open-label extension following completion of a 2-year randomized clinical trial—VIP Report No. 6. (In press)
2. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial—VIP report no. 1;Ophthalmology,2001
3. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group;Arch Ophthalmol,1991
4. Verteporfin in photodynamic therapy-Report No. 5;Ophthalmology,2004
5. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins;Aiello;Proc Natl Acad Sci USA,1995
Cited by 90 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Aflibercept treatment for delayed retinotomy-associated choroidal neovascularization: A case report and literature review;Taiwan Journal of Ophthalmology;2024-01-05
2. Safety and efficacy of intravitreal injection of conbercept for the treatment of patients with choroidal neovascularization secondary to pathological myopia: Results from the SHINY study;Acta Ophthalmologica;2023-11-27
3. ASSESSMENT AND ROLE OF ARTERY–VEIN COMPLEX IN MYOPIC CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY;Retina;2023-09
4. Comparison of the outcome of limited protocol Ranibizumab injection in naïve choroidal neovascular membranes secondary to pathological myopia versus age-related macular degeneration;Journal of the Egyptian Ophthalmological Society;2023
5. Perforating scleral vessels adjacent to myopic choroidal neovascularization achieved a poor outcome after intravitreal anti-VEGF therapy;Frontiers in Medicine;2022-12-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3